SFG
SevenBridge Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,076
| Closed | -$333K | – | 225 |
|
|
2024
Q3 | $333K | Buy |
6,076
+425
| +8% | +$23.3K | 0.06% | 175 |
|
|
2024
Q2 | $279K | Hold |
5,651
| – | – | 0.06% | 176 |
|
|
2024
Q1 | $316K | Sell |
5,651
-625
| -10% | -$34.9K | 0.07% | 168 |
|
|
2023
Q4 | $393K | Hold |
6,276
| – | – | 0.09% | 139 |
|
|
2023
Q3 | $285K | Hold |
6,276
| – | – | 0.07% | 153 |
|
|
2023
Q2 | $352K | Buy |
6,276
+100
| +2% | +$5.61K | 0.09% | 142 |
|
|
2023
Q1 | $279K | Sell |
6,176
-125
| -2% | -$5.65K | 0.08% | 154 |
|
|
2022
Q4 | $256K | Buy |
6,301
+525
| +9% | +$21.3K | 0.07% | 159 |
|
|
2022
Q3 | $377K | Hold |
5,776
| – | – | 0.13% | 121 |
|
|
2022
Q2 | $351K | Buy |
5,776
+807
| +16% | +$49K | 0.14% | 105 |
|
|
2022
Q1 | $312K | Sell |
4,969
-30
| -0.6% | -$1.88K | 0.11% | 125 |
|
|
2021
Q4 | $379K | Sell |
4,999
-593
| -11% | -$45K | 0.11% | 123 |
|
|
2021
Q3 | $626K | Hold |
5,592
| – | – | 0.21% | 99 |
|
|
2021
Q2 | $905K | Buy |
5,592
+117
| +2% | +$18.9K | 0.3% | 87 |
|
|
2021
Q1 | $667K | Hold |
5,475
| – | – | 0.24% | 95 |
|
|
2020
Q4 | $838K | Buy |
+5,475
| New | +$838K | 0.33% | 81 |
|